Company Filing History:
Years Active: 2008
Title: Innovations of Toshiyuki Tanaka in Obesity Treatment
Introduction
Toshiyuki Tanaka is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of obesity treatment through his innovative research and development of pharmaceutical compositions. His work focuses on identifying compounds that can inhibit adipocyte differentiation, which is crucial in combating obesity and related diseases.
Latest Patents
Toshiyuki Tanaka holds a patent for "Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect." The objective of this invention is to identify compounds that have an inhibitory effect on adipocyte differentiation. The patent outlines the use of sesquiterpenoid derivatives, which are extracts from the Compositae plant, Calea, found in Central and South America. These derivatives have demonstrated an excellent inhibitory effect on the induction of adipocyte differentiation. The findings suggest that Calea extract or the sesquiterpenoid derivatives can be utilized in pharmaceutical and food compositions for the prevention, improvement, or treatment of obesity-related diseases.
Career Highlights
Toshiyuki Tanaka is associated with Meiji Dairies Corporation, where he continues to advance his research in the field of obesity treatment. His dedication to studying natural products has led to significant breakthroughs in understanding how to combat obesity through innovative compounds.
Collaborations
Toshiyuki Tanaka has collaborated with notable colleagues, including Munekazu Iinuma and Makoto Ubukata. Their combined efforts have contributed to the advancement of research in the field of adipocyte differentiation and obesity treatment.
Conclusion
Toshiyuki Tanaka's innovative work in developing sesquiterpenoid derivatives represents a significant advancement in the fight against obesity. His contributions to the field are expected to have a lasting impact on pharmaceutical and food compositions aimed at preventing and treating obesity-related diseases.